Boji Medical Technology Co.,Ltd. (SHE:300404)
China flag China · Delayed Price · Currency is CNY
12.10
+0.21 (1.77%)
Nov 5, 2026, 4:00 PM EST

Boji Medical Technology Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
57.8830.4928.7824.3427.6738.88
Depreciation & Amortization
27.3727.6427.2323.2521.517.88
Other Amortization
8.017.743.664.232.831.46
Loss (Gain) From Sale of Assets
--0.210--
Asset Writedown & Restructuring Costs
0.010.010.080.030.070.3
Loss (Gain) From Sale of Investments
-2.32-2.32-3.04-2.78-3.75-2.36
Provision & Write-off of Bad Debts
26.4326.4320.3815.3614.928.32
Other Operating Activities
-37.037.718.587.627.277.79
Change in Accounts Receivable
-80.7-80.7-108.31-45.55-52.26-22.47
Change in Inventory
-41.94-41.948.24-33.51-23.49-56.55
Change in Accounts Payable
124.11124.1160.0857.0141.3538.69
Operating Cash Flow
69.6587.0126.7835.9528.1430.1
Operating Cash Flow Growth
37.61%224.90%-25.52%27.77%-6.52%-68.99%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-21.17-18.71-29.35-62.2-117.73-53.99
Sale of Property, Plant & Equipment
0.200.460.010.010.11
Investment in Securities
-32.64-29.91-40.9826.42-47.71-42.13
Other Investing Activities
19.072.213.022.683.412.49
Investing Cash Flow
-34.54-46.4-66.85-33.1-162.02-93.52

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-44.888.3356.0275.3125.13
Total Debt Issued
7.6244.888.3356.0275.3125.13
Long-Term Debt Repaid
--47.68-75.61-27.71-28.67-33.79
Lease Payments
-1.96-1.96-3.11-3.1-3.29-1.81
Total Debt Repaid
-10.9-47.68-75.61-27.71-28.67-33.79
Net Debt Issued (Repaid)
-3.27-2.8-67.2928.3146.64-8.66
Issuance of Common Stock
4.4826.313.3594.5912.14348.2
Repurchase of Common Stock
---15.65---
Common Dividends Paid
-7.67-5.92-7.58-8.04-6.84-1.2
Other Financing Activities
9.02-0.650.18-27.93-0.53-35.94
Financing Cash Flow
2.5616.93-86.9886.9351.41302.4

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-1.57-0.660.460.452.88-0.84
Net Cash Flow
36.156.87-126.690.23-79.59238.14

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
48.4968.3-2.57-26.24-89.59-23.89
Free Cash Flow Growth
53.17%-----
Free Cash Flow Margin
4.77%7.86%-0.35%-4.72%-21.15%-7.37%
Free Cash Flow Per Share
0.130.18-0.01-0.07-0.24-0.07
Levered Free Cash Flow
48.7858.633.33-47.08-106.39-62.77
Unlevered Free Cash Flow
49.6359.685.32-46.12-105.95-61.9
Free Cash Flow After Leases
46.5366.34-5.68-29.35-92.88-25.69

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
19.248.1338.9621.6710.1911.85
Change in Working Capital
-10.68-10.68-59.1-36.1-42.36-42.18